Lilly's Jaypirca gets EU approval recommendation for CLL
Eli Lilly and Company (NYSE: LLY) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
